Follow
Ozgur Tunceli
Ozgur Tunceli
Principal Scientist, Carelon Research
Verified email at carelon.com
Title
Cited by
Cited by
Year
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012
B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri, I Kalsekar, ...
BMJ Open Diabetes Research and Care 4 (1), e000154, 2016
2052016
Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone
MG de Verdier, M Andersson, DM Kern, S Zhou, O Tunceli
Value in Health 18 (6), 759-766, 2015
682015
Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States
DM Kern, S Zhou, S Chavoshi, O Tunceli, M Sostek, J Singer, ...
Am J Manag Care 21 (3), e222-e234, 2015
572015
Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a …
MH Kyaw, DM Kern, S Zhou, O Tunceli, HS Jafri, J Falloon
BMC health services research 15, 1-11, 2015
462015
Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods
O Tunceli, R Wade, T Gu, JR Bouchard, M Aagren, W Luo
Current medical research and opinion 26 (8), 1827-1834, 2010
422010
The use of migraine preventive medications among patients with and without migraine headaches
JE Lafata, O Tunceli, M Cerghet, KP Sharma, RB Lipton
Cephalalgia 30 (1), 97-104, 2010
412010
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller …
DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ...
Respiratory research 16, 1-12, 2015
392015
Cancer survivorship, health insurance, and employment transitions among older workers
K Tunceli, PF Short, JR Moran, O Tunceli
INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2009
392009
Impact of nonadherence to inhaled corticosteroid/LABA therapy on COPD exacerbation rates and healthcare costs in a commercially insured US population
JR Davis, B Wu, DM Kern, O Tunceli, KM Fox, J Horton, RF Legg, F Trudo
American health & drug benefits 10 (2), 92, 2017
382017
Applying weighting methodologies to a commercial database to project US Census demographic data
T Wasser, B Wu, WY Joseph, O Tunceli
MJH Life Sciences, 2015
332015
Assessment of outpatient and inpatient antibiotic treatment patterns and health care costs of patients with complicated urinary tract infections
RM Turner, B Wu, K Lawrence, J Hackett, S Karve, O Tunceli
Clinical therapeutics 37 (9), 2037-2047, 2015
332015
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ...
International journal of chronic obstructive pulmonary disease, 1417-1425, 2015
332015
Estimating the real-world cost of diabetes mellitus in the United States during an 8-year period using 2 cost methodologies
VJ Willey, S Kong, B Wu, A Raval, T Hobbs, A Windsheimer, ...
American Health & Drug Benefits 11 (6), 310, 2018
312018
Initiation patterns of statins in the 2 years after release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol management guideline in …
T Olufade, S Zhou, D Anzalone, DM Kern, O Tunceli, MJ Cziraky, ...
Journal of the American Heart Association 6 (5), e005205, 2017
292017
Increased burden of healthcare utilization and cost associated with opioid-related constipation among patients with noncancer pain
AW Fernandes, DM Kern, C Datto, YW Chen, C McLeskey, O Tunceli
American Health & Drug Benefits 9 (3), 160, 2016
282016
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
F Trudo, DM Kern, JR Davis, O Tunceli, S Zhou, EL Graham, C Strange, ...
International journal of chronic obstructive pulmonary disease, 2055-2066, 2015
262015
Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population
DM Kern, C Mellström, PR Hunt, O Tunceli, B Wu, M Westergaard, ...
Current medical research and opinion 32 (4), 703-711, 2016
252016
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis
O Tunceli, SA Williams, DM Kern, H Elhefni, N Pethick, C Wessman, ...
The Journal of Allergy and Clinical Immunology: In Practice 2 (6), 719-726. e6, 2014
232014
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. BMJ Open Diabetes Res Care. 2016; 4 (1): e000154
B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri
BMJDRC-2015-000154, 2016
182016
Health care utilization and costs after initiating budesonide/formoterol combination or fluticasone/salmeterol combination among COPD patients new to ICS/LABA treatment
JR Davis, DM Kern, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ...
Journal of Managed Care & Specialty Pharmacy 22 (3), 293-304, 2016
142016
The system can't perform the operation now. Try again later.
Articles 1–20